830 related articles for article (PubMed ID: 16832122)
1. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
[TBL] [Abstract][Full Text] [Related]
2. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
3. Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
Lefebvre JL; Ang KK;
Head Neck; 2009 Apr; 31(4):429-41. PubMed ID: 19283793
[TBL] [Abstract][Full Text] [Related]
4. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
[TBL] [Abstract][Full Text] [Related]
5. Larynx preservation clinical trial design: summary of key recommendations of a consensus panel.
Ang KK
Oncologist; 2010; 15 Suppl 3():25-9. PubMed ID: 21036886
[TBL] [Abstract][Full Text] [Related]
6. Larynx preservation and survival trends: should there be concern?
Forastiere AA
Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631
[No Abstract] [Full Text] [Related]
7. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
[TBL] [Abstract][Full Text] [Related]
9. [Surgical management of laryngeal cancer and preservation of laryngeal function].
Zhang L; Luan X; Pan X; Xie G; Xu F; Liu D; Lei D
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1461-3. PubMed ID: 12509906
[TBL] [Abstract][Full Text] [Related]
10. Organ preservation for advanced laryngeal carcinoma.
Foote RL; Foote RT; Brown PD; Garces YI; Okuno SH; Strome SE
Head Neck; 2006 Aug; 28(8):689-96. PubMed ID: 16619278
[TBL] [Abstract][Full Text] [Related]
11. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
[TBL] [Abstract][Full Text] [Related]
12. Organ preservation therapy for advanced-stage laryngeal carcinoma.
Hoffman HT; McCulloch T; Gustin D; Karnell LH
Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
[TBL] [Abstract][Full Text] [Related]
13. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.
Wolf GT; Bradford CR; Urba S; Smith A; Eisbruch A; Chepeha DB; Teknos TN; Worden F; Dawson L; Terrell JE; Hogikyan ND
Laryngoscope; 2002 Aug; 112(8 Pt 1):1351-6. PubMed ID: 12172244
[TBL] [Abstract][Full Text] [Related]
14. [Surgical management of aged patients with hypopharyngeal carcinoma and preservation of laryngeal function].
Zhang DG; Luan XY; Pan XL; Xie G
Ai Zheng; 2005 Nov; 24(11):1372-5. PubMed ID: 16552966
[TBL] [Abstract][Full Text] [Related]
15. The laryngologist in organ preservation for laryngeal cancer.
Brasnu DF; Hartl DM
Laryngoscope; 2008 Apr; 118(4):759-60. PubMed ID: 18300709
[No Abstract] [Full Text] [Related]
16. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
17. Larynx preservation.
Lefebvre JL
Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based review of treatment options for patients with glottic cancer.
Hartl DM; Ferlito A; Brasnu DF; Langendijk JA; Rinaldo A; Silver CE; Wolf GT
Head Neck; 2011 Nov; 33(11):1638-48. PubMed ID: 21990228
[TBL] [Abstract][Full Text] [Related]
19. Organ-preservation surgery following failed radiotherapy for laryngeal cancer. Evaluation, patient selection, functional outcome and survival.
Marioni G; Marchese-Ragona R; Lucioni M; Staffieri A
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):141-6. PubMed ID: 18327033
[TBL] [Abstract][Full Text] [Related]
20. What is the price of functional surgical organ preservation in local-regionally advanced supraglottic cancer? Long-term outcome for partial laryngectomy followed by radiotherapy in 32 patients.
Alterio D; Ansarin M; Jereczek-Fossa BA; Zorzi S; Santoro L; Zerini D; Massaro M; Rondi E; Ferrario S; Piperno G; Cossu Rocca M; Griseri M; Preda L; Chiesa F; Orecchia R
Tumori; 2013; 99(6):667-75. PubMed ID: 24503789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
